Company Search:
Advanced Search
Sponsored Links
Vidipha Central Pharmaceutical JSC Company Snapshot
Vidipha Central Pharmaceutical JSC operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vidipha Central Pharmaceutical JSC with three other companies in this sector in VIETNAM : Central Pharmaceutical JSC No3 (2020 sales of 397.56 billion Vietnamese Dong [US$17.25 million] ), Mediplantex National Pharmaceutical JSC (521.39 billion Vietnamese Dong [US$22.63 million] ), and Agimexpharm Pharmaceutical JSC (494.98 billion Vietnamese Dong [US$21.48 million] ).

Sales Analysis. Vidipha Central Pharmaceutical JSC reported sales of 696.13 billion Vietnamese Dong (US$30.21 million) for the year ending December of 2020. This represents an increase of 12.4% versus 2019, when the company's sales were 619.25 billion Vietnamese Dong . Sales at Vidipha Central Pharmaceutical JSC have increased during each of the previous five years (and since 2015, sales have increased a total of 80%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Vidipha Central Pharmaceutical JSC
  Stock Performance Chart for Vidipha Central Pharmaceutical JSC
  Stock Data: Recent Stock Performance:
  Current Price (2/26/2021): 33,000
(Figures in Vietnamese Dong )
1 Week 0.6%   13 Weeks 4.8%  
4 Weeks 0.3%   52 Weeks 6.5%  
Vidipha Central Pharmaceutical JSC Key Data:
  Ticker: VDP Country: Vietnam
  Exchanges: HCM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 696,131,655,247
(Year Ending Jan 2021).
Employees: 445
  Currency: Vietnamese Dong Market Cap: 421,835,832,000
  Fiscal Yr Ends: December Shares Outstanding: 12,782,904
  Share Type: Ordinary Closely Held Shares: 7,533,381
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.